Think Bioscience

About

Think Bioscience is a biotechnology company based in Colorado, dedicated to developing small-molecule therapeutics for challenging disease targets. Co-founded by CEO Jerome Fox, the company utilizes synthetic biology and interdisciplinary methods to tackle diseases such as diabetes, cancer, autoimmune disorders, and neurological conditions. The company operates as a biomolecular innovation engine, focusing on microbial engineering and rapid iteration to discover novel drug scaffolds. Its team comprises synthetic biologists, medicinal chemists, enzymologists, and computational chemists, all working together to identify allosteric inhibitors and brain-penetrant molecules. Think Bioscience targets key areas like protein tyrosine phosphatases and kinases, as well as transcription factors linked to various diseases. Think Bioscience collaborates with academic institutions, including CU Boulder and NYU, to enhance its platform and optimize molecules. The company is also engaging with pharmaceutical partners for expertise in target discovery and drug development. Recently, it extended its seed funding to advance its innovative "pocket-finding" platform, which identifies novel binding sites on difficult targets.